Details for New Drug Application (NDA): 204028
✉ Email this page to a colleague
The generic ingredient in DESVENLAFAXINE SUCCINATE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
Summary for 204028
Tradename: | DESVENLAFAXINE SUCCINATE |
Applicant: | Rubicon |
Ingredient: | desvenlafaxine succinate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 204028
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204028 | ANDA | Advagen Pharma Ltd | 72888-143 | 72888-143-00 | 1000 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-143-00) |
DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204028 | ANDA | Advagen Pharma Ltd | 72888-143 | 72888-143-05 | 500 TABLET, EXTENDED RELEASE in 1 PACKAGE (72888-143-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Jun 29, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Jun 29, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Dec 7, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription